What's new? Log in Free sign up

Table search / GSK plc / "Pandemic"

9 results

Newest first Best match first

Annual report (foreign)

2024 £m	2023 £m	Growth £%	Growth CER%
Total Group turnover	31,376	30,328	3	7
Total Group pandemic	12	194	(94)	(94)
Total Group turnover ex COVID-19 solutions	31,364	30,134	4	8

3 Mar 25

11:03am

Annual report (foreign)

2024 £m	2023 £m	Growth £%	Growth CER%
Total	16,384	15,820	4	6
Pandemic	10	10	–	10
Excluding COVID	16,374	15,810	4	6

3 Mar 25

11:03am

Annual report (foreign)

2024 £m	2023 £m	Growth £%	Growth CER%
Total	6,666	6,564	2	4
Pandemic	1	133	(99)	(99)
Excluding COVID	6,665	6,431	4	6

3 Mar 25

11:03am

Annual report (foreign)

2024 £m	2023 £m	Growth £%	Growth CER%
Total	8,326	7,944	5	11
Pandemic	1	51	(97)	>(100)
Excluding COVID	8,325	7,893	5	12

3 Mar 25

11:03am

Annual report (foreign)

2024 £m	2023 £m	Growth £%	Growth CER%
Total Specialty Medicines	11,810	10,244	15	19
Pandemic	12	44	(73)	(73)
Speciality Medicines ex COVID-19 solutions	11,798	10,200	16	19

3 Mar 25

11:03am

Annual report (foreign)

3 Mar 25

11:03am

0eosdpr642dpybf1bj0

Annual report (foreign)

3 Mar 25

11:03am

8gk7wtj33h7u4a 5wuc

Annual report (foreign)

3 Mar 25

11:03am

Annual report (foreign)

5 Mar 24

12:10pm

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.